COMMUNIQUÉS West-GlobeNewswire

Valneva annonce un report de la date de début de remboursement du prêt contracté avec les sociétés Deerfield et OrbiMed
18/03/2024
Les remboursements sont différés de 18 mois et débuteront en janvier 2026 au lieu de juillet 2024 Saint-Herblain (France), le 18 mars 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les [...]
Idorsia and Viatris successfully close the transaction for the global research and development collaboration
18/03/2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – March 18, 2024 Idorsia Ltd (SIX: IDIA) today announced that it has successfully closed the transaction with Viatris Inc. (NASDAQ: VTRS), a global [...]
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
18/03/2024
Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI ® , the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss [...]
Financière de Tubize - Annual report 2023
16/03/2024
FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report 2023 Regulated information 16 March 2024 The board of directors of Financière de Tubize [...]
Financière de Tubize - Rapport annuel 2023
16/03/2024
FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: investorrelations@financiere-tubize.be Rapport annuel 2023 Information réglementée 16 mars 2024 Le conseil d’administration de la Financière de [...]
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
16/03/2024
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has postponed the release of its [...]
Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics
16/03/2024
Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a cutting-edge clinic driven by developing [...]
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
15/03/2024
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on March 11, 2024, it received two letters from the listing qualifications department staff of The Nasdaq [...]
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
15/03/2024
TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company, developing regenerative medicine [...]
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
15/03/2024
SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics [...]
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
15/03/2024
ReOpen was th e first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis patients without nasal polyps Clinical trial program also [...]
Sanofi: Information concerning the total number of voting rights and shares - February 2024
15/03/2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2024
15/03/2024
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
15/03/2024
The certification has the potential to open access to Islamic markets globally, expanding potential markets for Scilex’s innovative FDA approved non-opioid therapies and pipeline candidate products. The certification is [...]
Gain Therapeutics to Present at Public Ventures Discovery Day
15/03/2024
Gain Therapeutics’ Former CEO and current Board Member Eric Richman to participate in fireside chat hosted by Public Ventures President Lou Basenese and Aberdeen Investment Management President Jeb Terry, Sr. BETHESDA, [...]
Ibogaine By David Dardashti: Government Urged to Increase Funding for Quantum Electrodynamics Research
15/03/2024
Exploring the Relationship Between Glial Cells and Electromagnetic Waves MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti today announced that they are advocating to the government to increase [...]
Quantum Electrodynamics and Chaos Theory Enhance Ibogaine's Psychological Experience
15/03/2024
Ibogaine By David Dardashti applies the principles of Quantum Electrodynamics and Chaos Theory to optimize the ibogaine experience MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is introducing a [...]
Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
15/03/2024
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leader in digital transformation solutions including managed services, [...]
SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
15/03/2024
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for [...]

Pages